Personalized Medicines: A Futuristic Healthcare System
Keywords:
Biomarkers, Drugs, Genes, Phenotype, Personalized medicineAbstract
Personalized medicine is the study of DNA analysis and genetic information through different techniques and implication of this for selection of Right Drug for Right Patient. It is enabling sources to shift Healthcare system's 'one size fits all' approach to precise way treatment. Biomarkers, Gene sequencing, Gene annotation, etc are utilized to provide personalized medicine to the patient. Well it is developing field but still it has some application such as Determine eligibility of HIV patients for treatment with Selzentry (maraviroc), identifying the patients with breast cancer who can be treated through Herceptin, etc. In personalized medicine, doctor diagnoses a sufferer's gene with regard to lifestyle and environmental factors, prescribe a drug which will be the best for the treatment of Patient. To provide the best medical management strategies for preventing and curing a disease, this system involves in understanding of diseases on molecular level. All the information gathered from molecular studies are used for providing Supreme Healthcare strategies for preventing and curing a disease. We hope it will be more useful in future than we think.
References
Savard J. Personalised medicine: A critique on the future of health care. J Bioeth Inq. 2013;10(2):197-203. Available from: https://pubmed.ncbi.nlm.nih.gov/23515958/
Cruz-Correia R, Ferreira D, Bacelar G, Marques P, Maranhão P. Personalised medicine challenges: Quality of data. Int J Data Sci Anal. 2018;6(3):251-9. Available from: https://doi.org/10.1007/s41060-018-0127-9
S A. Personalized medicine: a tailor made medicine. Avicenna journal of medical biotechnology. 2018 [cited 2025 Mar 24];6(4). Available from: https://pubmed.ncbi.nlm.nih.gov/25414780
Jain KK. Nanobiotechnology and personalized medicine. In: Handbook of Nanotechnology. 2012. p. 451-4. Available from: https://pubmed.ncbi.nlm.nih.gov/22093223
Cohen P. Personalized aging: One size doesn’t fit all. In: The Upside of Aging. 2014. p. 19-33. Available from: https://doi.org/10.1002/9781118691823.ch2
Agyeman AA, Ofori-Asenso R. Perspective: Does personalized medicine hold the future for medicine? J Pharm Bioallied Sci. 2015;7(3):239-44. Available from: https://pubmed.ncbi.nlm.nih.gov/26229361
Harvey A, Brand A, Holgate ST, Kristiansen LV, Lehrach H, Palotie A, Prainsack B. The future of technologies for personalised medicine. New Biotechnol. 2012;29(6):625-33. Available from: https://pubmed.ncbi.nlm.nih.gov/23091837
Schmidt S. The Case for Personalized Medicine 2014 4 Th Edition [Internet]. 2014. Available from: https://www.personalizedmedicinecoalition.org/userfiles/pmc-corporate/file/pmc_the_case_for_personalized_medicine.pdf
Ablin RJ. The need for personalized therapy and companion diagnostics in prostate cancer. Biomark Med. 2011;5(3):281-3. Available from: https://pubmed.ncbi.nlm.nih.gov/21657837
Rahman M. Effects of Hypofractionated Radiotherapy in Advanced Stage of Non-Small Cell Type Bronchogenic Carcinoma. Scholar’s journal of applied medical sciences. 2022 Aug 17;10(8):1271–6. https://saspublishers.com/article/5942/
Koen N, Du Preez I, Loots DT. Metabolomics and personalized medicine. Adv Protein Chem Struct Biol. 2016;102:53-78. Available from: https://pubmed.ncbi.nlm.nih.gov/26827602
Khodadadian A, Darzi S, Haghi-Daredeh S, Eshaghi FS, Babakhanzadeh E, Mirabutalebi SH, Nazari M. Genomics and transcriptomics: The powerful technologies in precision medicine. Int J Gen Med. 2020; 13:627-40. Available from: https://pubmed.ncbi.nlm.nih.gov/32982380
Liu S. Epigenetics advancing personalized nanomedicine in cancer therapy. Adv Drug Deliv Rev. 2012;64(13):1532-43. Available from: https://pubmed.ncbi.nlm.nih.gov/22921595
Lee MS, Flammer AJ, Lerman LO, Lerman A. Personalized medicine in cardiovascular diseases. Korean Circ J. 2012; 42(9):583. Available from: https://pubmed.ncbi.nlm.nih.gov/23091501
Huss R. Personalized cell therapy—Biomarker & companion diagnostics. In: Advances in Pharmaceutical Cell Therapy. 2015. p. 401-13. Available from: https://doi.org/10.1142/9789814616799_0011
Fossella JA, Casey BJ. Genes, brain, and behavior: Bridging disciplines. Cogn Affect Behav Neurosci. 2006;6(1):1-8. Available from: https://pubmed.ncbi.nlm.nih.gov/16869224
Lu X, Fu X, Wang D, Wang J, Chen X, Hao M, et al. Resequencing of cv cri-12 family reveals haplotype block inheritance and recombination of agronomically important genes in artificial selection. Plant Biotechnol J. 2018;16(5):945-55. Available from: https://pubmed.ncbi.nlm.nih.gov/30407717
Ellsworth DL, Manolio TA. The emerging importance of genetics in epidemiologic research II. Issues in study design and gene mapping. Ann Epidemiol. 1999;9(2):75-90. Available from: https://pubmed.ncbi.nlm.nih.gov/10037550
Brandacher G, Golderer G, Kienzl K, Werner ER, Margreiter R, Weiss HG. Potential applications of global protein expression analysis (proteomics) in morbid obesity and bariatric surgery. Obes Surg. 2008;18(7):905-10. https://pubmed.ncbi.nlm.nih.gov/18330661.
Graves PR, Haystead TAJ. Molecular biologist's guide to proteomics. Microbiol Mol Biol Rev. 2002;66(1):39-63. Available from: https://pubmed.ncbi.nlm.nih.gov/11875127.
Boopathi NM. Curtain Raiser to Novel MAS Platforms. Genetic Mapping and Marker Assisted Selection. 2012 Nov 15;193–244.doi: https://doi.org/10.1007/978-81-322-0958-4_10
Simopoulos AP, Ordovas JM. Nutrigenetics and nutrigenomics. World Rev Nutr Diet. 2004; 96:303-11. doi: https://doi.org/10.1159/000109814.
Serre JL. Techniques and tools in molecular biology used in genetic diagnoses. Diagnostic Techniques in Genetics. 2006 Aug 25: 1-59.https://doi.org/10.1002/0470033363.ch1
Mitsui J, Ishiura H, Tsuji S. DNA sequencing and other methods of exonic and genomic analyses. In: Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease. 2025 Jan 1. p. 131-42.https://doi.org/10.1016/B978-0-443-19041-4.00051-0
Mathur S, Sutton J. Personalized medicine could transform healthcare. Biomedical reports. 2017 Jul 1;7(1):3-5. doi: https://doi.org/10.3892/br.2017.922
McCubrey JA, Abrams SL, Fitzgerald TL, Cocco L, Martelli AM, Montalto G, Cervello M, Scalisi A, Candido S, Libra M, Steelman LS. Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis. Advances in biological regulation. 2015 Jan 1; 57:75-101. doi: https://doi.org/10.1016/j.jbior.2014.09.016
Dracopoli NC, Grewal I, Takimoto CH, Lebowitz PF. Personalized Medicine in Oncology Drug Development. Holland‐Frei Cancer Medicine. 2016 Oct 17:1-9. https://doi.org/10.1002/9781119000822.hfcm052
A Tan: Ongoing Adjuvant Trials withTrastuzumabin Breast Cancer. Seminars in Oncology2003: Tan AR, Swain SM. Ongoing adjuvant trials with trastuzumab in breast cancer. InSeminars in oncology 2003 Oct 1 (Vol. 30, pp. 54-64). WB Saunders. https://doi.org/10.1053/j.seminoncol.2003.08.008
You JH. Pharmacoeconomic evaluation of warfarin pharmacogenomics. Expert opinion on pharmacotherapy. 2011 Feb 1;12(3):435-41. doi: https://doi.org/10.1517/14656566.2011.521153
Alfirevic A, Pirmohamed M, Marinovic B, Harcourt‐Smith L, Jorgensen AL, Cooper TE. Genetic testing for prevention of severe drug‐induced skin rash. Cochrane database of systematic reviews. 2019(7). doi: https://doi.org/10.1002/14651858.CD010891.pub2.
Ruane PJ, Kubota MK, Williams AL, Arroyo JC, Canas A, Richmond GJ, Alsop C, Yau L, Hessenthaler SM, Hernandez JE. Safety/tolerability and efficacy of abacavir-containing combination therapy in HIV-1-infected adults in a clinical practice setting: results of ZORRO. Infectious Diseases in Clinical Practice. 2004 Jan 1;12(1):15-25. doi: https://doi.org/10.1097/01.idc.0000104895.16995.8d
Pirmohamed M, Drummond NS, Naisbitt DJ, Park BK. Drug hypersensitivity reactions in patients with HIV disease. Expert Review of Clinical Immunology. 2007 May 1;3(3):395-410. doi: https://doi.org/10.1586/1744666X.3.3.395
Clarkson PJ, Buckle P, Coleman R, Stubbs D, Ward J, Jarrett J, Lane R, Bound J. Design for patient safety: a review of the effectiveness of design in the UK health service. Journal of Engineering Design. 2004 Apr 1;15(2):123-140. https://doi.org/10.1080/09544820310001617711
Tercyak kenneth P. Handbook of Genomics and the Family. Issues in clinical child psychology. Springer; 2010. https://link.springer.com/book/10.1007/978-1-4419-5800-6
Alagiakrishnan K, Gill SS, Fagarasanu A. Genetics and epigenetics of Alzheimer's disease. Postgraduate medical journal. 2012 Sep; 88(1043):522- 529. https://doi.org/10.1136/postgradmedj-2011-130363
Wilkes G. Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents. Asia-Pacific Journal of Oncology Nursing. 2018;5(2):137. https://doi.org/10.4103/apjon.apjon_79_17
Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. New England Journal of Medicine. 2011 Mar 24;364(12): 1144-53. https://www.nejm.org/doi/full/10.1056/NEJMra1010600
Peter J, Choshi P, Lehloenya RJ. Drug hypersensitivity in HIV infection. Current opinion in allergy and clinical immunology. 2019 Aug 1;19(4): 272-282. https://pubmed.ncbi.nlm.nih.gov/31145192/
Quinney SK, Patil AS, Flockhart DA. Is personalized medicine achievable in obstetrics? InSeminars in perinatology 2014 Dec 1 (Vol. 38, No. 8, pp. 534-540). https://doi.org/10.1053/j.semperi.2014.08.017
Canese R, Bazzocchi A, Blandino G, Carpinelli G, De Nuccio C, Gion M, Moretti F, Soricelli A, Spessotto P, Iorio E. The role of molecular and imaging biomarkers in the evaluation of inflammation in oncology. The International Journal of Biological Markers. 2020 Feb;35(1_suppl):5-7. https://pubmed.ncbi.nlm.nih.gov/32079466
Meng Y, Sun J, Qu N, Zhang G, Yu T, Piao H. Application of Radiomics for Personalized Treatment of Cancer Patients. Cancer Management and Research. 2019;11:10851–8. https://doi.org/10.2147/cmar.s232473
Valeska MD, Adisurja GP, Bernard S, Wijaya RM, Hafidzhah MA, Parikesit AA. The role of bioinformatics in personalized medicine: your future medical treatment. Cermin Dunia Kedokteran. 2019;46(12): 785–788. https://doi.org/10.55175/cdk.v46i12.399
Grigoriadou M, Schulpis KH, Kokotas H. Molecular genetics and gene therapy aspects of phenylalanine hydroxylase (PAH) related hyperphenylalaninemias. J Genet Syndr Gene Ther. 2014;5: e125. https://www.longdom.org/archive/jgsgt-volume-5-issue-6-year-2014.html
Wang S, Huang T. Applications of deep learning in biomedicine. Syst Med. 2021; 1:29-39. https://doi.org/10.1016/B978-0-12-801238-3.11507-7
